Last reviewed · How we verify
Lipid emulsion without progesterone — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Lipid emulsion without progesterone (Lipid emulsion without progesterone) — BHR Pharma, LLC. A lipid emulsion formulation that delivers lipophilic compounds without progesterone as an active pharmaceutical ingredient.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lipid emulsion without progesterone TARGET | Lipid emulsion without progesterone | BHR Pharma, LLC | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lipid emulsion without progesterone CI watch — RSS
- Lipid emulsion without progesterone CI watch — Atom
- Lipid emulsion without progesterone CI watch — JSON
- Lipid emulsion without progesterone alone — RSS
Cite this brief
Drug Landscape (2026). Lipid emulsion without progesterone — Competitive Intelligence Brief. https://druglandscape.com/ci/lipid-emulsion-without-progesterone. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing